| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |